公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials | Jensen D.M.; Asselah T.; Dieterich D.; Foster G.R.; Sulkowski M.S.; Zeuzem S.; Mantry P.; Yoshida E.M.; Moreno C.; Ouzan D.; Wright M.; Morano L.E.; Buynak R.; Bourlière M.; Hassanein T.; Nishiguchi S.; JIA-HORNG KAO ; Omata M.; Paik S.W.; Wong D.K.; Tam E.; Kaita K.; Victor Feinman S.; Stern J.O.; Scherer J.; Quinson A.-M.; Voss F.; Gallivan J.-P.; Böcher W.O.; Ferenci P. | Annals of Hepatology | 1 | 0 | |
2013 | Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial | ANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. | Journal of Clinical Oncology | 619 | 599 | |
1993 | Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests | CHIEN D.Y.; CHOO Q.‐L.; TABRIZI A.; KUO C.; McFARLAND J.; BERGER K.; Lee, Cha-Ze ; SHUSTER J.R.; NGUYEN T.; MOYER D.L.; TONG M.; FURUTA S.; OMATA M.; FONG C.T.; TEGTMEIER G.; ALTER H.; SCHIFF E.; JEFFERS L.; HOUGHTON M.; KUO G. | Journal of Gastroenterology and Hepatology | 7 | 0 |